FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4382393506> ?p ?o ?g. }

• W4382393506 endingPage "102787" @default.
• W4382393506 startingPage "102787" @default.
• W4382393506 abstract "Cisplatin (CP) is a top-notch anti-cancerous agent which is used during the treatments of various types of tumors. Tamarixetin (TM) is a naturally occurring polyphenolic compound with versatile therapeutic and pharmacological abilities. This investigation was purposed to elucidate the antagonistic effects of TM against CP-prompted renal intoxication. Sprague Dawley rats (n = 48) were separated into 4 equal groups i.e., Group 1st was the untreated, assigned as control group while the 2nd group was treated with CP only, group 3rd received CP + TM and designated as a co-treated group while group 4th was administered with TM only. Our results revealed that treatment of CP reduced the activity of catalase (CAT), glutathione peroxidase (GPx), superoxide dismutase (SOD), glutathione-disulfide reductase (GSR), glutathione S-transferase (GST) as well as glutathione (GSH) while elevate ROS and MDA levels. CP administration raised the level of urea, creatinine, KIM1 along with NGAL while significant reduction in creatinine clearance. Whereas, CP treatment substantially elevated the level of caspase-3, caspase- 9 and Bcl-2 associated X protein (Bax) while reducing the level of B cell lymphoma protein 2 (Bcl-2). CP administration significantly elevated the concentration of nuclear factor kappa-B (NF-kB), interleukin 6 (IL-6), interleukin 1 beta (IL-1β) as well as tumor necrosis factor α (TNF-α), and instigated histopathological damages in renal tissues. However, Co-treatment of CP + TM showed palliative effects against CP-induced impairments. The current study manifested that TM is a potential flavonoid that could be used as therapeutic drug to ameliorate the damages instigated by CP." @default.
• W4382393506 created "2023-06-29" @default.
• W4382393506 creator A5007550327 @default.
• W4382393506 creator A5019172820 @default.
• W4382393506 creator A5033529252 @default.
• W4382393506 creator A5046154856 @default.
• W4382393506 creator A5063811019 @default.
• W4382393506 creator A5067996250 @default.
• W4382393506 date "2023-08-01" @default.
• W4382393506 modified "2023-10-14" @default.
• W4382393506 title "Evaluation of possible palliative role of tamarixetin against cisplatin-induced renal toxicity by modulation of oxidative stress, inflammation and apoptosis in rats" @default.
• W4382393506 cites W1643026548 @default.
• W4382393506 cites W191793640 @default.
• W4382393506 cites W1975980695 @default.
• W4382393506 cites W1979690981 @default.
• W4382393506 cites W1983310681 @default.
• W4382393506 cites W1983965827 @default.
• W4382393506 cites W1990867240 @default.
• W4382393506 cites W1998784256 @default.
• W4382393506 cites W2005349781 @default.
• W4382393506 cites W2049870923 @default.
• W4382393506 cites W2056523973 @default.
• W4382393506 cites W2069132215 @default.
• W4382393506 cites W2112340294 @default.
• W4382393506 cites W2114889530 @default.
• W4382393506 cites W2140473720 @default.
• W4382393506 cites W2152482616 @default.
• W4382393506 cites W2160675185 @default.
• W4382393506 cites W2534855805 @default.
• W4382393506 cites W2560551564 @default.
• W4382393506 cites W2725743431 @default.
• W4382393506 cites W2768339055 @default.
• W4382393506 cites W2790286901 @default.
• W4382393506 cites W2805751882 @default.
• W4382393506 cites W2806695428 @default.
• W4382393506 cites W2808557521 @default.
• W4382393506 cites W2891289417 @default.
• W4382393506 cites W2899290392 @default.
• W4382393506 cites W2946434301 @default.
• W4382393506 cites W2992920647 @default.
• W4382393506 cites W3025810098 @default.
• W4382393506 cites W3049428234 @default.
• W4382393506 cites W3208867698 @default.
• W4382393506 cites W4200323722 @default.
• W4382393506 cites W4292199349 @default.
• W4382393506 cites W2245949816 @default.
• W4382393506 doi "https://doi.org/10.1016/j.jksus.2023.102787" @default.
• W4382393506 hasPublicationYear "2023" @default.
• W4382393506 type Work @default.
• W4382393506 citedByCount "0" @default.
• W4382393506 crossrefType "journal-article" @default.
• W4382393506 hasAuthorship W4382393506A5007550327 @default.
• W4382393506 hasAuthorship W4382393506A5019172820 @default.
• W4382393506 hasAuthorship W4382393506A5033529252 @default.
• W4382393506 hasAuthorship W4382393506A5046154856 @default.
• W4382393506 hasAuthorship W4382393506A5063811019 @default.
• W4382393506 hasAuthorship W4382393506A5067996250 @default.
• W4382393506 hasBestOaLocation W43823935061 @default.
• W4382393506 hasConcept C126189478 @default.
• W4382393506 hasConcept C126322002 @default.
• W4382393506 hasConcept C134018914 @default.
• W4382393506 hasConcept C165069038 @default.
• W4382393506 hasConcept C181199279 @default.
• W4382393506 hasConcept C185592680 @default.
• W4382393506 hasConcept C190283241 @default.
• W4382393506 hasConcept C2775838275 @default.
• W4382393506 hasConcept C2776151105 @default.
• W4382393506 hasConcept C2778760513 @default.
• W4382393506 hasConcept C2779179908 @default.
• W4382393506 hasConcept C2780091579 @default.
• W4382393506 hasConcept C2780306776 @default.
• W4382393506 hasConcept C538909803 @default.
• W4382393506 hasConcept C55493867 @default.
• W4382393506 hasConcept C71924100 @default.
• W4382393506 hasConcept C98274493 @default.
• W4382393506 hasConceptScore W4382393506C126189478 @default.
• W4382393506 hasConceptScore W4382393506C126322002 @default.
• W4382393506 hasConceptScore W4382393506C134018914 @default.
• W4382393506 hasConceptScore W4382393506C165069038 @default.
• W4382393506 hasConceptScore W4382393506C181199279 @default.
• W4382393506 hasConceptScore W4382393506C185592680 @default.
• W4382393506 hasConceptScore W4382393506C190283241 @default.
• W4382393506 hasConceptScore W4382393506C2775838275 @default.
• W4382393506 hasConceptScore W4382393506C2776151105 @default.
• W4382393506 hasConceptScore W4382393506C2778760513 @default.
• W4382393506 hasConceptScore W4382393506C2779179908 @default.
• W4382393506 hasConceptScore W4382393506C2780091579 @default.
• W4382393506 hasConceptScore W4382393506C2780306776 @default.
• W4382393506 hasConceptScore W4382393506C538909803 @default.
• W4382393506 hasConceptScore W4382393506C55493867 @default.
• W4382393506 hasConceptScore W4382393506C71924100 @default.
• W4382393506 hasConceptScore W4382393506C98274493 @default.
• W4382393506 hasFunder F4320321145 @default.
• W4382393506 hasIssue "6" @default.
• W4382393506 hasLocation W43823935061 @default.
• W4382393506 hasOpenAccess W4382393506 @default.
• W4382393506 hasPrimaryLocation W43823935061 @default.
• W4382393506 hasRelatedWork W1994127376 @default.

• next